And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...

We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its third-quarter 2025 results on Nov. 3, after ...

V2X, Inc. (NYSE:VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2.25 ...

KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results ...

Semiconductor testing company FormFactor (NASDAQ:FORM) will be reporting earnings this Wednesday after market hours. Here’s what to expect. FormFactor beat analysts’ revenue expectations by 3.4% last ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...

South Rampart Pharma is working to develop an oral small molecule non-opioid pain treatment which has generated early positive clinical data as a therapy for acute and chronic pain, as well as ...

Solana Company ("Solana" or the "Company") today announced that it has applied to the British Columbia Securities Commission, as principal regulator, and the Ontario Securities Commission, for an ...

Expert-Backed Tips For Regowing Your Hair This article was reviewed by Knox Beasley, MD. Ask the internet how to get thicker ...

Learn more about whether BioMarin Pharmaceutical Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.